Citigroup
BDSX icon

Citigroup’s Biodesix BDSX Stock Holding History

Citigroup’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31K Buy
+58
New +$860 ﹤0.01% 5395
2025
Q3 		– Sell
-4
Closed -$22 – 6087
2025
Q2 		$22 Sell
4
-229
-98% -$1.85K ﹤0.01% 5566
2025
Q1 		$2.91K Sell
233
-3,910
-94% -$75K ﹤0.01% 5324
2024
Q4 		$127K Buy
4,143
+2,109
+104% +$62.1K ﹤0.01% 4708
2024
Q3 		$72.4K Buy
+2,034
New +$70K ﹤0.01% 4899
2024
Q2 		– Sell
-3,564
Closed -$102K – 5580
2024
Q1 		$102K Buy
3,564
+1,433
+67% +$49K ﹤0.01% 4285
2023
Q4 		$78.4K Buy
+2,131
New +$66.9K ﹤0.01% 4307
2022
Q4 		– Hold
0
– – – 5775
2022
Q3 		– Sell
-58
Closed -$2.24K – 5833
2022
Q2 		$2K Buy
58
+8
+16% +$260 ﹤0.01% 5855
2022
Q1 		$2K Sell
50
-106
-68% -$6.93K ﹤0.01% 6041
2021
Q4 		$17K Buy
156
+85
+120% +$11.1K ﹤0.01% 5426
2021
Q3 		$12K Buy
71
+42
+145% +$7.97K ﹤0.01% 5419
2021
Q2 		$8K Buy
29
+19
+190% +$5.97K ﹤0.01% 5731
2021
Q1 		$4K Sell
10
-7
-41% -$3.13K ﹤0.01% 5930
2020
Q4 		$7K Buy
+17
New +$5.29K ﹤0.01% 7032

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Citigroup's BDSX Position: Q2 2026 in Review

Citigroup opened a new position in Biodesix (BDSX) in Q2 2026: 58 shares worth $1.31K. The stake represents ﹤0.01% of the portfolio and ranks #5395 among its holdings. This is a return to the name: Citigroup previously reported a position in BDSX as recently as Q2 2025.

Citigroup first reported a position in BDSX in Q4 2020 and has held it in 14 quarters since. The position peaked at $127K in Q4 2024. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Citigroup held 58 shares of Biodesix worth $1.31K as of Q2 2026.
  • Biodesix was a new Citigroup position in Q2 2026.
  • Biodesix made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5395 holding.
  • Citigroup first reported a position in Biodesix in Q4 2020 and has held it in 14 quarters since.
  • Citigroup's Biodesix position peaked at $127K in Q4 2024.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.